|
Product Candidates
|
Indication
|
R&D Status
|
Agreement Status
|
Territory Available
|
|
TriptoSar
|
|
Phase
I Human trials - US, France
|
PFM
|
China,
Taiwan & Hong Kong
|
|
WilGraf
|
Organ
transplantation, autoimmune & skin
|
Primates
|
Option
agreement w/ Fujisawa
|
Worldwide
|
|
WilVent
|
Lung
diseases
-Pulmonary
fibrosis
-Obliterative
airway disease & SARS
|
Small
animal
|
Open
|
Worldwide
|
|
NeurTriptin
|
Neuroprotection
-
Alzheimer’s
-
Parkinson’s
-
ALS diseases
|
In
vitro
|
Open
|
Worldwide
|
|
PG27
|
Rheumatoid
arthritis
|
Small
animals
|
PhytoHealth
- Taiwan
|
Rest
of world excluding China & Taiwan
|
|
Injectable
Astragalus Polysaccharide
(PG2)
|
Adjunctive
treatment to cancer therapy
Restores
WBCs
|
Product
launch
|
TJHL
– China
|
Rest
of world excluding China & Taiwan
|
|
XueBao
(PG2)
|
Adjunctive
treatment to cancer therapy
Restores
WBCs
|
Phase
II Human
trials
|
PhytoHealth
- Taiwan
|
Rest
of world excluding China & Taiwan
|
|
AstraStim
|
Adjunctive
treatment to cancer therapy
Restores WBCs, RBCs and Platelets
|
Small
animals
|
Open
|
Worldwide
|
|
PG36
|
CMV
Infection
|
Small
animals
|
Open
|
Worldwide
|